Claris Biotherapeutics: Funding, Investors & Team (Oct 2026)
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Claris Biotherapeutics has raised $118M across 1 funding round on record, the most recent a Series B of $118M announced in Jul 2026.
That round is above the $7.6M median round size for United States companies tracked on FundedIQ over the last two years.
Claris Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Claris Biotherapeutics Funding Rounds
Claris Biotherapeutics Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
Claris Biotherapeutics Founders and Leadership Team
Contact details for the Claris Biotherapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Claris Biotherapeutics Funding in Context
Claris Biotherapeutics' latest round of $118M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Claris Biotherapeutics in Biopharma and Jersey City
Companies Similar to Claris Biotherapeutics
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…
Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…
PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…
Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…
Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…
Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…
Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…
Park Golf Pitch & Putt is a sports company that focuses on outdoor entertainment with focus on pitch-putt…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Voltus represents the "potential of us" to better manage energy through simple, cost and risk-free…
Claris Biotherapeutics Funding FAQs
What does Claris Biotherapeutics do?
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
How much funding has Claris Biotherapeutics raised?
Claris Biotherapeutics has raised $118M across 1 round on record. The most recent is a Series B of $118M announced in Jul 2026.
When did Claris Biotherapeutics last raise funding?
Claris Biotherapeutics' most recent funding round on record is a Series B of $118M, announced in Jul 2026.
Who has invested in Claris Biotherapeutics?
Investors on record for Claris Biotherapeutics include RA Capital Management, Catalio Capital Management, Janus Henderson Investors, Samsara BioCapital, Novo Holdings. FundedIQ records 10 investors in total.
Who is the CEO of Claris Biotherapeutics?
Clarke Atwell is listed as CEO and President at Claris Biotherapeutics.
Where is Claris Biotherapeutics headquartered?
Claris Biotherapeutics is based in Jersey City, United States.
How many employees does Claris Biotherapeutics have?
Claris Biotherapeutics is in the 1-10 employee band.
When was Claris Biotherapeutics founded?
Claris Biotherapeutics was founded in 2018.
About FundedIQ's Claris Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Claris Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.